FDA Approves Neurotech Company for Testing Brain Chip in Humans

 

Activist Post reports that brain-computer interface, or BCI, represents the latest frontier of artificial intelligence and biology. While this technology is still early in development, a growing number of companies are already looking at its commercial applications.

On July 28, one of those companies, New York startup Synchron, received FDA approval to test its brain device in human patients. Stentrode, Synchron’s implantable device is small enough to be implanted via a blood vessel at the base of the neck. The device is then maneuvered toward a vessel in the brain.

Stentrode works by communicating through a tiny wire with a second implant in the chest. A transmitter then sends signals to an external computer near the patient.

“We have worked together to pave a pathway forward, towards the first commercial approval for a permanently implanted BCI for the treatment of paralysis”, Thomas Oxley, Synchron CEO, said via Activist Post.

The company plans to enroll six patients in its U.S. trial later this year. According to Oxley, the U.S. study will take a closer look at safety issues, including physical risks and cybersecurity. Activist Post reports an FDA-approved product could be on the market in as soon as 3 to 5 years.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Global Sales
Success Stories and Strategy Sharing: Ankiit Parikh on the Power of Global Sales Meetings
April 9, 2026

In an increasingly interconnected global economy, the ability for organizations to align across regions has become less of a luxury and more of a necessity. Events like global sales meetings serve as critical convergence points where diverse perspectives, market insights, and success stories are exchanged, often sparking innovation that transcends geographic boundaries. What…

Read More
Sales
Global Alignment in Action: Insights from Dirk de Mulder at the IPS Global Sales Meeting in Mexico City
April 9, 2026

In an increasingly interconnected manufacturing landscape, global alignment is no longer a strategic advantage—it’s a necessity. Companies like TekniPlex are leaning into this reality by rethinking how their teams collaborate across continents, recognizing that innovation often happens at the intersection of diverse markets. The shift from presentation-heavy meetings to interactive workshops reflects a…

Read More
Global
One Industry, One Vision: Philippe Chabot Reflects on Global Alignment at IPS Mexico City
April 9, 2026

In an increasingly interconnected manufacturing landscape, companies like TekniPlex are redefining what it means to operate across borders, blending regional expertise with global coordination. The liners and packaging sector, in particular, has become a proving ground for how technical precision and international collaboration can coexist to meet evolving market demands. Professionals navigating this…

Read More
Global
A First-Time Perspective on Global Alignment: Yun Qi on Collaboration and Momentum at IPS Mexico City 2026
April 8, 2026

Global sales meetings often serve as more than just strategic checkpoints—they are cultural touchstones that reveal how organizations align across borders, functions, and perspectives. In an increasingly interconnected market, the ability to harness shared energy and translate it into meaningful collaboration can define whether a company simply operates globally or truly thinks globally….

Read More